PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31632071-0	2019	Long Noncoding RNA HCP5 Regulates Pancreatic Cancer Gemcitabine (GEM) Resistance By Sponging Hsa-miR-214-3p To Target HDGF.	gemcitabine	52-63	microRNA 214	Homo sapiens	97-104	
31632071-0	2019	Long Noncoding RNA HCP5 Regulates Pancreatic Cancer Gemcitabine (GEM) Resistance By Sponging Hsa-miR-214-3p To Target HDGF.	gemcitabine	65-68	microRNA 214	Homo sapiens	97-104	
31632071-10	2019	Conclusion: Our results revealed that lncRNA HCP5 is highly expressed in HCC, and development of GEM-resistance PC cells involving the processes of proliferation, invasive, migration, cell apoptosis and autophagy through the miR-214-3p/HDGF axis.	gemcitabine	97-100	microRNA 214	Homo sapiens	225-232	
21106054-6	2010	In vitro experiments showed that overexpression of miR-15a inhibited the viability of pancreatic cancer cells, whereas overexpression of miR-214 decreased the sensitivity of the cells to gemcitabine (GEM).	gemcitabine	187-198	microRNA 214	Homo sapiens	137-144	
21106054-6	2010	In vitro experiments showed that overexpression of miR-15a inhibited the viability of pancreatic cancer cells, whereas overexpression of miR-214 decreased the sensitivity of the cells to gemcitabine (GEM).	gemcitabine	200-203	microRNA 214	Homo sapiens	137-144	
27296953-11	2016	The combination of gemcitabine plus vinorelbine was well tolerated as second-line treatment for platinum-based chemotherapy-refractory esophageal cancer patients and appeared to provide enhanced clinical activity especially in patients with low expression of miRNA-214.	gemcitabine	19-30	microRNA 214	Homo sapiens	259-268